214 related articles for article (PubMed ID: 16434259)
1. Multimodality treatment of unresectable stage III non-small cell lung cancer: interim analysis of a phase II trial with preoperative gemcitabine and concurrent radiotherapy.
Galetta D; Cesario A; Margaritora S; Porziella V; Piraino A; D'Angelillo RM; Gambacorta MA; Ramella S; Trodella L; Valente S; Corbo GM; Macis G; Mulè A; Cardaci V; Sterzi S; Granone P; Russo P
J Thorac Cardiovasc Surg; 2006 Feb; 131(2):314-21. PubMed ID: 16434259
[TBL] [Abstract][Full Text] [Related]
2. Incidental surgical findings of a phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with unresectable non-small cell lung cancer.
Cesario A; Margaritora S; Trodella L; Valente S; Corbo GM; Macis G; Galetta D; d'Angelillo RM; Porziella V; Ramella S; Mangiacotti MG; Granone P
Lung Cancer; 2002 Aug; 37(2):207-12. PubMed ID: 12140144
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
Zwitter M; Kovac V; Smrdel U; Strojan P
J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of gemcitabine with concurrent radiotherapy on stage III,inoperable non-small cell lung cancer].
Li GZ; Zhang SH; Zhang Z; Wang RL
Ai Zheng; 2007 Dec; 26(12):1377-80. PubMed ID: 18076806
[TBL] [Abstract][Full Text] [Related]
5. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
Argiris A; Liptay M; LaCombe M; Marymont M; Kies MS; Sundaresan S; Masters G
Lung Cancer; 2004 Aug; 45(2):243-53. PubMed ID: 15246197
[TBL] [Abstract][Full Text] [Related]
6. Multimodality treatment of stage III non-small cell lung cancer: analysis of a phase II trial using preoperative cisplatin and gemcitabine with concurrent radiotherapy.
D'Angelillo RM; Trodella L; Ciresa M; Cellini F; Fiore M; Greco C; Pompeo E; Mineo TC; Paleari L; Granone P; Ramella S; Cesario A
J Thorac Oncol; 2009 Dec; 4(12):1517-23. PubMed ID: 19875976
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer.
Lee DH; Han JY; Cho KH; Pyo HR; Kim HY; Yoon SJ; Lee JS
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1037-44. PubMed ID: 16024178
[TBL] [Abstract][Full Text] [Related]
8. Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small-cell lung cancer.
Trodella L; Granone P; Valente S; Turriziani A; Macis G; Corbo GM; Margaritora S; Cesario A; D'Angelillo RM; Gualano G; Ramella S; Galetta D; Cellini N
J Clin Oncol; 2002 Feb; 20(3):804-10. PubMed ID: 11821464
[TBL] [Abstract][Full Text] [Related]
9. Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer.
Abacioglu U; Yumuk PF; Caglar H; Sengoz M; Turhal NS
BMC Cancer; 2005 Jul; 5():71. PubMed ID: 16000167
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II study.
Kosmidis P; Fountzilas G; Baka S; Samantas E; Dimopoulos AM; Gogas H; Skarlos D; Papacostas P; Boukovinas J; Bakogiannis Ch; Pantelakos P; Athanasiou H; Misailidou D; Tsekeris P; Pavlidis N
Anticancer Res; 2007; 27(6C):4391-5. PubMed ID: 18214050
[TBL] [Abstract][Full Text] [Related]
11. A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC).
Schallier D; Neyns B; Fontaine C; Steene JV; De Mey J; Meysman M; De Grève J
Lung Cancer; 2007 May; 56(2):247-54. PubMed ID: 17337086
[TBL] [Abstract][Full Text] [Related]
12. A 3-week schedule of gemcitabine plus cisplatin as induction chemotherapy for Stage III non-small cell lung cancer.
Migliorino MR; De Marinis F; Nelli F; Facciolo F; Ammaturo MV; Cipri A; Belli R; Ariganello O; Diana F; Di Molfetta M; Martelli O
Lung Cancer; 2002 Mar; 35(3):319-27. PubMed ID: 11844608
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer: a phase I study.
Gagel B; Piroth M; Pinkawa M; Reinartz P; Zimny M; Fischedik K; Stanzel S; Breuer C; Skobel E; Asadpour B; Schmachtenberg A; Buell U; Eble MJ
Strahlenther Onkol; 2006 May; 182(5):263-9. PubMed ID: 16673059
[TBL] [Abstract][Full Text] [Related]
14. Phase Ia/Ib chemo-radiation trial of gemcitabine and dose-escalated thoracic radiation in patients with stage III A/B non-small cell lung cancer.
Blackstock AW; Ho C; Butler J; Fletcher-Steede J; Case LD; Hinson W; Miller AA
J Thorac Oncol; 2006 Jun; 1(5):434-40. PubMed ID: 17409896
[TBL] [Abstract][Full Text] [Related]
15. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.
Reboul F; Brewer Y; Vincent P; Chauvet B; Faure CF; Taulelle M
Int J Radiat Oncol Biol Phys; 1996 May; 35(2):343-50. PubMed ID: 8635942
[TBL] [Abstract][Full Text] [Related]
16. [A phase II multicenter study of gemcitabine in non small cell lung cancers].
Le Chevalier T; Gottfried M; Gatzemeier U; Shepherd F; Weynants P; Cottier B; Groen HJ; Rosso R; Mattson K; Cortes-Funes H; Tonato M; Burkes RL; Voi M; Ponzio A
Bull Cancer; 1997 Mar; 84(3):282-8. PubMed ID: 9207875
[TBL] [Abstract][Full Text] [Related]
17. [Remission rate of mediastinal lymph nodes after multimodal therapy of lung cancer--is it a prognostic factor?].
Granetzny A; Striehn E; Bosse U; Wagner W; Koch O; Vogt U; Froeschle P; Klinke F
Zentralbl Chir; 2003 Aug; 128(8):640-4. PubMed ID: 12931258
[TBL] [Abstract][Full Text] [Related]
18. Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.
Niho S; Kubota K; Goto K; Ohmatsu H; Matsumoto T; Kakinuma R; Nishiwaki Y
Cancer Chemother Pharmacol; 2003 Jul; 52(1):19-24. PubMed ID: 12712259
[TBL] [Abstract][Full Text] [Related]
19. Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.
Hirsh V; Soulieres D; Duclos M; Faria S; Del Vecchio P; Ofiara L; Ayoub JP; Charpentier D; Gruber J; Portelance L; Souhami L
J Thorac Oncol; 2007 Oct; 2(10):927-32. PubMed ID: 17909355
[TBL] [Abstract][Full Text] [Related]
20. Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study.
Gagel B; Piroth M; Pinkawa M; Reinartz P; Krohn T; Kaiser HJ; Stanzel S; Breuer C; Asadpour B; Schmachtenberg A; Eble MJ
BMC Cancer; 2007 Jun; 7():112. PubMed ID: 17598906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
